- Home
- OOMA vs LXRX Comparison
OOMA vs LXRX Comparison
Compare OOMA & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OOMA
- LXRX
- Stock Information
- Founded
- OOMA 2003
- LXRX 1995
- Country
- OOMA United States
- LXRX United States
- Employees
- OOMA N/A
- LXRX N/A
- Industry
- OOMA EDP Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- OOMA Technology
- LXRX Health Care
- Exchange
- OOMA Nasdaq
- LXRX Nasdaq
- Market Cap
- OOMA 379.7M
- LXRX 428.8M
- IPO Year
- OOMA 2015
- LXRX 2000
- Fundamental
- Price
- OOMA $12.05
- LXRX $1.19
- Analyst Decision
- OOMA Buy
- LXRX Buy
- Analyst Count
- OOMA 6
- LXRX 5
- Target Price
- OOMA $17.63
- LXRX $3.23
- AVG Volume (30 Days)
- OOMA 115.6K
- LXRX 2.5M
- Earning Date
- OOMA 08-26-2025
- LXRX 08-06-2025
- Dividend Yield
- OOMA N/A
- LXRX N/A
- EPS Growth
- OOMA N/A
- LXRX N/A
- EPS
- OOMA N/A
- LXRX N/A
- Revenue
- OOMA $259,382,000.00
- LXRX $58,432,000.00
- Revenue This Year
- OOMA $6.33
- LXRX N/A
- Revenue Next Year
- OOMA $6.15
- LXRX N/A
- P/E Ratio
- OOMA N/A
- LXRX N/A
- Revenue Growth
- OOMA 7.01
- LXRX 1504.83
- 52 Week Low
- OOMA $8.25
- LXRX $0.28
- 52 Week High
- OOMA $17.00
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- OOMA 56.72
- LXRX 56.85
- Support Level
- OOMA $11.32
- LXRX $1.12
- Resistance Level
- OOMA $11.80
- LXRX $1.27
- Average True Range (ATR)
- OOMA 0.28
- LXRX 0.09
- MACD
- OOMA 0.11
- LXRX -0.00
- Stochastic Oscillator
- OOMA 94.44
- LXRX 68.00
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.